Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deedra Nicolet

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|November 28, 2024
Genotype-immunophenotype relationships in <i>NPM1</i>-mutant AML clonal evolution uncovered by single cell multiomic analysisMorgan Drucker, Darren Lee, Xuan Zhang, et al.
Blood Advances|August 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology studyBhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, et al.
Leukemia|February 10, 2019
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyKrzysztof Mrózek, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Haematologica|August 16, 2019
Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemiaMarius Bill, Deedra Nicolet, Jessica Kohlschmidt, et al.
Leukemia|June 7, 2018
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcomeAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Blood Advances|July 12, 2018
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remissionSumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Innovation (Cambridge (Mass.))|November 12, 2024
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemiaKellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|November 28, 2024
Genotype-immunophenotype relationships in <i>NPM1</i>-mutant AML clonal evolution uncovered by single cell multiomic analysisMorgan Drucker, Darren Lee, Xuan Zhang, et al.
Blood Advances|August 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology studyBhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, et al.
Leukemia|February 10, 2019
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyKrzysztof Mrózek, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Haematologica|August 16, 2019
Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemiaMarius Bill, Deedra Nicolet, Jessica Kohlschmidt, et al.
Leukemia|June 7, 2018
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcomeAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Blood Advances|July 12, 2018
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remissionSumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Innovation (Cambridge (Mass.))|November 12, 2024
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemiaKellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Pageof 8